Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WentzMiller Global Services is a private consulting firm focused on continuing medical education and continuing professional development strategy, health publishing, and related business advisory work. The company appears to serve pharmaceutical companies, medical societies, medical education providers, and healthcare information businesses rather than developing therapeutics of its own. Publicly available descriptions characterize WentzMiller as helping clients design and implement global CME/CPD initiatives, expand internationally, recruit medical experts, and shape the business case for medical education programs. A 2020 partnership announcement with Zhongchao positioned WentzMiller as a U.S.-based advisor supporting distribution of healthcare training content and medical expert engagement. Based on available evidence, it should be classified as a healthcare-oriented advisory/services company rather than a biotech, pharma developer, CRO, or therapeutics platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WentzMiller Global Services.